Hyperuricemia
Navigation Links
Hyperuricemia in Medical News
FDA approves ULORIC (febuxostat) for the chronic management of hyperuricemia in patients with gout
... 40 mg and 80 mg for the chronic management of hyperuricemia in patients with gout. This once-daily, oral ... for the more than five million patients who have hyperuricemia associated with gout. ULORIC was discovered by ... offers clinicians and their patients who have hyperuricemia associated with gout a new treatment option that ...... Center in Philadelphia, Pennsylvania. "Untreated gout and prolonged hyperuricemia can lead to an accumulation of needle-like urate crystals that not only ... to reduce urate crystal accumulation and prevent the consequences of hyperuricemia and gout. It is important to work with your physician to monitor ...
AUA 2008: Uric acid stones may indicate arteriosclerotic diseases
... and urinary stone disease and concluded that arteriosclerotic diseases and hyperuricemia can be predictors of uric acid stones. 77.5 percent of all patients in ... 2 diabetes, but the proportion of uric acid stones in elderly men with hyperuricemia and arteriosclerotic disease was significantly higher. Metabolic ...... people with gout should not interpret a lack of symptoms as a "cure." Even when painful symptoms are not present, untreated gout and prolonged hyperuricemia can lead to permanent joint damage and deformity. Most experts agree that lowering a person's uric acid level to less than 6.0 mg/dL is helpful to ...
Review of Takeda's Febuxostat New Drug Application Continues Past PDUFA Date
... look forward to receiving a final approval date for febuxostat." Febuxostat is currently under review with FDA for once-daily, oral treatment of hyperuricemia in patients with gout. The NDA for febuxostat included data from multiple clinical trials involving more than 4,000 patients. In November 2008, ...Pegloticase BLA Filing Accepted for Priority Review by FDA
... ABOUT PEGLOTICASE Pegloticase (formerly referred to as Puricase(R)) is a pegylated recombinant mammalian urate oxidase in development to control hyperuricemia and its clinical consequences in patients for whom conventional therapy is contraindicated or has been ineffective. The two Phase 3 pivotal trials ...Basketball Star Details His Struggle With Gout
... Americans, and to debunk stereotypes about the so-called "disease of kings." According to GUAES, gouty arthritis results from a condition known as hyperuricemia -- the build-up of abnormally high levels of uric acid in the blood. A normal waste product that forms from the breakdown of purines found in cells ...Risk Of Heart Attack Increased By Gout
... up of uric acid in blood. When chronic or severe hyperuricemia leads to urate crystals within joints, it results ... Blood Institute. There were 5,337 men with hyperuricemia at the beginning of the study. Over the study ... atherogenesis and thrombogenesis is needed. hyperuricemia is well known to be an independent risk factor ...Hyperuricemia in Medical Technology
... the FDA approve febuxostat for the treatment of hyperuricemia in patients with gout. The vote was 12 to zero in ... be the first new treatment for the management of hyperuricemia associated with gout in more than 40 years.
... approval of febuxostat for the treatment of hyperuricemia in patients with gout, is a positive step in ...
... clinical efficacy study in gout patients with hyperuricemia in the first half of 2008. The Company is ... approved by the FDA for the treatment of hyperuricemia associated with gout in the past 40 years, ... 8% experienced serious adverse events (1). hyperuricemia in HIV There is a high prevalence ...
... (p=0.0012). The PUA response rate among patients with baseline hyperuricemia defined as plasma uric acid >7.5mg/dL was 90% with Elitek versus 53% ... at either high or potential risk for TLS: High risk for TLS was defined as hyperuricemia from the cancer at baseline (plasma uric acid >7.5 mg/dL), very ...
... dizziness (3% vs 1%) -- AEs reported in >2% of patients taking BENICAR HCT(R) and more frequently than placebo included nausea (3% vs 0%), hyperuricemia (4% vs 2%), dizziness (9% vs 2%), and upper respiratory tract infection (7% vs 0%) Dosing and Administration No initial dosage ...
... was dizziness (3% vs 1%) -- AEs reported in > 2% of patients taking BENICAR HCT and more frequently than placebo included nausea (3% vs 0%), hyperuricemia (4% vs 2%), dizziness (9% vs 2%), and upper respiratory tract infection (7% vs 0%) Dosing and Administration -- No initial dosage adjustments ...
... vs 1 percent). AEs reported in > 2 percent of patients taking BENICAR HCT and more frequently than placebo included nausea (3 percent vs 0 percent), hyperuricemia (4 percent vs 2 percent), dizziness (9 percent vs 2 percent), and upper respiratory tract infection (7 percent vs 0 percent). No initial dosage ...
... clinical efficacy study in gout patients with hyperuricemia in the first half of 2008. The Company is ... approved by the FDA for the treatment of hyperuricemia associated with gout in the past 40 years, ... 8% experienced serious adverse events (1). hyperuricemia in HIV There is a high prevalence ...
... (p=0.0012). The PUA response rate among patients with baseline hyperuricemia defined as plasma uric acid >7.5mg/dL was 90% with Elitek versus 53% ... at either high or potential risk for TLS: High risk for TLS was defined as hyperuricemia from the cancer at baseline (plasma uric acid >7.5 mg/dL), very ...
Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594
... Doses of RDEA806, A Novel Prodrug for the Potential Treatment of hyperuricemia Location: Le Palais de Congres de Paris - Level 1 (Abstract # THU0356) ... No new therapies have been approved by the FDA for the treatment of hyperuricemia associated with gout in the past 40 years. About RDEA594 RDEA594 is a ...... dizziness (3% vs 1%) -- AEs reported in >2% of patients taking BENICAR HCT(R) and more frequently than placebo included nausea (3% vs 0%), hyperuricemia (4% vs 2%), dizziness (9% vs 2%), and upper respiratory tract infection (7% vs 0%) Dosing and Administration No initial dosage ...
New Report by BioTrends Research Group to Highlight the Launch of ULORIC(R) (febuxostat)
... received FDA approval for Uloric (R) (generic name: febuxostat) on February 13, 2009. Uloric (R) is indicated for the chronic management of hyperuricemia associated with gout and represents the first product for gout that has been approved in over forty years. LaunchTrends(TM): Uloric (R) ...Savient Provides Update on Pegloticase BLA
... KRYSTEXXA (pegloticase) (formerly referred to as Puricase(R)) is a pegylated recombinant mammalian urate oxidase in development to control hyperuricemia and its clinical consequences in patients for whom conventional therapy is contraindicated or has been ineffective. The two Phase 3 pivotal trials ...... was dizziness (3% vs 1%) -- AEs reported in > 2% of patients taking BENICAR HCT and more frequently than placebo included nausea (3% vs 0%), hyperuricemia (4% vs 2%), dizziness (9% vs 2%), and upper respiratory tract infection (7% vs 0%) Dosing and Administration -- No initial dosage adjustments ...
... vs 1 percent). AEs reported in > 2 percent of patients taking BENICAR HCT and more frequently than placebo included nausea (3 percent vs 0 percent), hyperuricemia (4 percent vs 2 percent), dizziness (9 percent vs 2 percent), and upper respiratory tract infection (7 percent vs 0 percent). No initial dosage ...
Hyperuricemia in Medical Definition
... 2 O Dehydration / Hypervolemia - K + Hypokalemia / Hyperkalemia - Cl − Hyperchloremia / Hypochloremia
Purine and pyrimidine
hyperuricemia - Lesch-Nyhan syndrome - Xanthinuria
Porphyrin
Acute intermittent , Gunther's , Cutanea tarda , Erythropoietic , ...
Hyperuricemia in Medical Dictionary
... that high blood levels of uric acid ( hyperuricemia ) may be a risk indicator for heart disease . ... caused by too much uric acid in the blood ( hyperuricemia ). hyperuricemia usually does no harm, and most people with high ...
... Note: hyperuricemia does not inevitably lead to gout . In fact, ... disease . Acute Gouty Arthritis ... hyperuricemia occurs most often in men and in postmenopausal ... But if untreated, it can lead to: ... hyperuricemia Excessively high levels of uric acid in the ...
... elevated levels of uric acid in the blood ( hyperuricemia ). Uric acid is a waste product formed from ... caused by too much uric acid in the blood ( hyperuricemia ). hyperuricemia usually does no harm, and most people with high ...
... Too much thyroid hormone . Symptoms include weight loss , chest pain , cramps , diarrhea , and nervousness. Also called overactive thyroid. hyperuricemia ... ...
... disease such as diabetic retinopathy ( eye disease ) or ... High blood sugar ( hyperglycemia ). Too much uric acid in the blood ( hyperuricemia ). Excess uric acid in the blood can lead to gout . Gastrointestinal problems such as upset stomach , gas, nausea , vomiting , and ...
... . Tumor lysis syndrome results from rapid breakdown of malignant cells resulting in a number of metabolic abnormalities, most notably hyperuricemia , hyperkalemia , and hyperphosphatemia. hyperkalemia - high amounts of potassium in the blood ; can be diagnose d by blood test, or by ...
... Too much thyroid hormone . Symptoms include weight loss , chest pain , cramps , diarrhea , and nervousness. Also called overactive thyroid. hyperuricemia ... Radioactive iodine used to treat hyperthyroid ism (overactive thyroid) or radiation treatment s for head or neck cancer s can destroy ...
... Too much thyroid hormone . Symptoms include weight loss , chest pain , cramps , diarrhea , and nervousness. Also called overactive thyroid. hyperuricemia ... Radioactive iodine used to treat hyperthyroidism (overactive thyroid) or radiation treatment s for head or neck cancer s can destroy the ...
... Too much thyroid hormone . Symptoms include weight loss , chest pain , cramps , diarrhea , and nervousness. Also called overactive thyroid. hyperuricemia ... ANOREXIA : Lack or loss of appetite that causes significant weight loss . ANOSCOPY : A visual examination of the anal canal with an ...
... Note: hyperuricemia does not inevitably lead to gout . In fact, ... disease . Acute Gouty Arthritis ... hyperuricemia occurs most often in men and in postmenopausal ... But if untreated, it can lead to: ... hyperuricemia Excessively high levels of uric acid in the ...
... elevated levels of uric acid in the blood ( hyperuricemia ). Uric acid is a waste product formed from ... caused by too much uric acid in the blood ( hyperuricemia ). hyperuricemia usually does no harm, and most people with high ...
... Too much thyroid hormone . Symptoms include weight loss , chest pain , cramps , diarrhea , and nervousness. Also called overactive thyroid. hyperuricemia ... ...
... disease such as diabetic retinopathy ( eye disease ) or ... High blood sugar ( hyperglycemia ). Too much uric acid in the blood ( hyperuricemia ). Excess uric acid in the blood can lead to gout . Gastrointestinal problems such as upset stomach , gas, nausea , vomiting , and ...
... . Tumor lysis syndrome results from rapid breakdown of malignant cells resulting in a number of metabolic abnormalities, most notably hyperuricemia , hyperkalemia , and hyperphosphatemia. hyperkalemia - high amounts of potassium in the blood ; can be diagnose d by blood test, or by ...
... Too much thyroid hormone . Symptoms include weight loss , chest pain , cramps , diarrhea , and nervousness. Also called overactive thyroid. hyperuricemia ... Radioactive iodine used to treat hyperthyroid ism (overactive thyroid) or radiation treatment s for head or neck cancer s can destroy ...
... Too much thyroid hormone . Symptoms include weight loss , chest pain , cramps , diarrhea , and nervousness. Also called overactive thyroid. hyperuricemia ... Radioactive iodine used to treat hyperthyroidism (overactive thyroid) or radiation treatment s for head or neck cancer s can destroy the ...
... Too much thyroid hormone . Symptoms include weight loss , chest pain , cramps , diarrhea , and nervousness. Also called overactive thyroid. hyperuricemia ... ANOREXIA : Lack or loss of appetite that causes significant weight loss . ANOSCOPY : A visual examination of the anal canal with an ...
Hyperuricemia in Biological Technology
... 40 mg and 80 mg for the chronic management of hyperuricemia in patients with gout. This once-daily, oral ... for the more than five million patients who have hyperuricemia associated with gout. ULORIC was discovered by ... offers clinicians and their patients who have hyperuricemia associated with gout a new treatment option that ...
... markets. Savient is currently developing one product: KRYSTEXXA(TM) (pegloticase) as a therapy for patients with treatment failure gout, to control hyperuricemia and to manage the signs and symptoms of gout. Savient has exclusively licensed worldwide rights to the technology related to KRYSTEXXA, formerly ...
... 1, 2009. ABOUT KRYSTEXXA(TM) KRYSTEXXA (TM) (pegloticase) is a pegylated recombinant mammalian urate oxidase in development to control hyperuricemia and its clinical consequences in patients for whom conventional therapy is contraindicated or has been ineffective. The two Phase 3 pivotal trials ...
Ardea Biosciences' Advances RDEA806 Into Phase 2a Proof-of-Concept Study for Gout
... normal sUA concentrations in gout patients with hyperuricemia (greater than or equal to 8.0 mg/dl). The primary ... related to rheumatology, and most frequently to hyperuricemia and gout. About Gout An estimated 3-5 million ... been approved by the FDA for the treatment of hyperuricemia associated with gout in the past 40 years. ...... markets. Savient is currently developing one product: KRYSTEXXA(TM) (pegloticase) as a therapy for patients with treatment failure gout, to control hyperuricemia and to manage the signs and symptoms of gout. Savient has exclusively licensed worldwide rights to the technology related to KRYSTEXXA, formerly ...
... 1, 2009. ABOUT KRYSTEXXA(TM) KRYSTEXXA (TM) (pegloticase) is a pegylated recombinant mammalian urate oxidase in development to control hyperuricemia and its clinical consequences in patients for whom conventional therapy is contraindicated or has been ineffective. The two Phase 3 pivotal trials ...
Other ContentsdentistrydentistrydeodorantsdermabrasiondermatologydermatologydermatologydermatologydermatologydermatomyositisdesensitizationdesensitizationdetacheddetacheddetacheddetacheddetacheddetergentsdetergentsdetergentsdetergentsOther TagsEmbolismEndoscopy
(Date:11/30/2009)... leaves them without treatment for blood-borne dis...30 (HealthDay News) -- Many medical students get s...rne diseases, but they often fail to alert hospita...tion, a new study has found. , The researchers ...nters and found that 415 -- 59 percent -- had expe...
(Date:11/30/2009)..., NEW ORLEANS, Nov. 30 /PRNewswire-USNewswire/ -...s of the global corporation Sodexo will hold a ral...ties and Maintenance headquarters, 3800 Desire Par...e policy and arbitrary disciplinary policies that ...or an ill family member. Sodexo employees who clea...
(Date:11/30/2009)..., CHARLTON, Mass., Nov. 30 Harrin...ce the addition of Family Practice physicians Mart... Mathur to its Charlton practice. ,, These fo... coming from the Fallon Clinic, will soon join the...e at Charlton medical office building under constr...
(Date:11/30/2009)...is a tiny period of time between the registration ...ur conscious recognition of it ― between the... as an apple. Our minds lag behind our eyes, but b... to the world around us? , Some estimates say ... say 500 milliseconds. A new study by Tel Aviv Uni...
(Date:11/30/2009)..., social skills improve with specially designed pr...HealthDay News) -- A special, intensive early inte...d in boosting IQ along with children,s language an...e in this fashion, many children are able to learn...son, lead author of the study, published online No...
Breaking Medicine News(10 mins):Health News:Med Students Often Fail to Report Needlestick Injuries 2Health News:As H1NI Hits New Orleans in Force: School Custodians to Hold Rally to Call on Contractor to Stop Penalizing Workers Coping With Illness 2Health News:Family Practice Physicians Martin Devine, Leah Doret, Elizabeth Fuller and Monika Mathur Join Harrington Physician Services in Charlton 2Health News:Family Practice Physicians Martin Devine, Leah Doret, Elizabeth Fuller and Monika Mathur Join Harrington Physician Services in Charlton 3Health News:Now you see it, now you know you see it 2Health News:Working Intensely Early on May Help Autistic Kids 2Health News:Working Intensely Early on May Help Autistic Kids 3Health News:Working Intensely Early on May Help Autistic Kids 4[0] Med Students Often Fail to Report Needlestick Injuries [1] As H1NI Hits New Orleans in Force: School Custodians to Hold Rally to Call on Contractor to Stop Penalizing Workers Coping With Illness[0] Family Practice Physicians Martin Devine, Leah Doret, Elizabeth Fuller and Monika Mathur Join Harrington Physician Services in Charlton[0] Now you see it, now you know you see it[0] Working Intensely Early on May Help Autistic Kids
(Date:11/25/2009)...hters, police officers and ambulance workers faced...ter complex. They battled to save people from the ...ckled fires and evacuated as many people as they c...0 people. And making their jobs even harder was th...rs and their relatives jammed mobile networks with...
(Date:11/25/2009)...etime, the heart pumps some 250 million liters of ...he muscle fibers of the heart have to be extremely...g Rottbauer, vice chair of the Department of Medic...n: Prof. Dr. H. A. Katus), has discovered a protei...llest muscular unit, the sarcomere. In cooperation...
(Date:11/24/2009)...t has been prescribed by traditional healers in Br...nd stomach pain to fever and flu. , Now for the f...e been able to scientifically prove the pain relie...wn as Brazilian mint. , Testing this ancient Sout...r Graciela Rocha was able to show that when prepar...
Breaking Biology News(10 mins):Magic box for mission impossible 2Magic box for mission impossible 3New genetic cause of cardiac failure discovered 2Got a pain? -- Have a cup of Brazilian mint 2Johnson 26 Johnson Highlights Pharmaceutical Growth Strategies and Robust Pipeline to Address Unmet Medical Needs 47899 1Johnson 26 Johnson Highlights Pharmaceutical Growth Strategies and Robust Pipeline to Address Unmet Medical Needs 47899 2Johnson 26 Johnson Highlights Pharmaceutical Growth Strategies and Robust Pipeline to Address Unmet Medical Needs 47899 3Johnson 26 Johnson Highlights Pharmaceutical Growth Strategies and Robust Pipeline to Address Unmet Medical Needs 47899 4Johnson 26 Johnson Highlights Pharmaceutical Growth Strategies and Robust Pipeline to Address Unmet Medical Needs 47899 5Johnson 26 Johnson Highlights Pharmaceutical Growth Strategies and Robust Pipeline to Address Unmet Medical Needs 47899 6Johnson 26 Johnson Highlights Pharmaceutical Growth Strategies and Robust Pipeline to Address Unmet Medical Needs 47899 7Abbott and AstraZeneca Extend Relationship to Include Co Promotion of TRILIPIX 28R 29 28fenofibric acid 29 47895 1Abbott and AstraZeneca Extend Relationship to Include Co Promotion of TRILIPIX 28R 29 28fenofibric acid 29 47895 2Abbott and AstraZeneca Extend Relationship to Include Co Promotion of TRILIPIX 28R 29 28fenofibric acid 29 47895 3Singapore to Host Inaugural Healthcare Travel Exhibition 26 Congress 47891 1Singapore to Host Inaugural Healthcare Travel Exhibition 26 Congress 47891 2Singapore to Host Inaugural Healthcare Travel Exhibition 26 Congress 47891 3EmbolismEmesisEmpyemaEncopresisEmptyEmergenciesEndocarditisEndometritisEndocrinologyEndometrialErosionEndophthalmitisEndoscopyEnema
Other Tagssettlement 2neglect 2neglect 3pleasure 2pleasure 3commitment 2commitment 3
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |